Hamilton Locke advised Tryptamine Therapeutics Limited on the deal. Tryptamine Therapeutics Limited secured the acquisition and backdoor listing of Tryp Therapeutics Inc., a biotechnology entity previously...
You must be a Standard 1 Year member to access this content.
Hamilton Locke advised Pioneer Lithium on the deal. Pioneer Lithium completed an initial public offering and listing on the ASX. The successful IPO raised $5 million for...
You must be a Standard 1 Year member to access this content.
Hamilton Locke advised Botala Energy Ltd on its successful initial public offering on the ASX under the ticker code “BTE”. The strongly supported IPO raised $5...
You must be a Standard 1 Year member to access this content.
